000 01253 a2200325 4500
005 20250518070938.0
264 0 _c20200417
008 202004s 0 0 eng d
022 _a0072-9752
024 7 _a10.1016/B978-0-444-64012-3.00025-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSienaert, Pascal
245 0 0 _aThe psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia.
_h[electronic resource]
260 _bHandbook of clinical neurology
_c2019
300 _a415-428 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aBenzodiazepines
_xtherapeutic use
650 0 4 _aCatatonia
_xdrug therapy
650 0 4 _aDystonia
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aNeuroleptic Malignant Syndrome
_xdrug therapy
650 0 4 _aPsychomotor Agitation
_xdrug therapy
650 0 4 _aPsychopharmacology
650 0 4 _aTardive Dyskinesia
_xdrug therapy
700 1 _avan Harten, Peter
700 1 _aRhebergen, Didi
773 0 _tHandbook of clinical neurology
_gvol. 165
_gp. 415-428
856 4 0 _uhttps://doi.org/10.1016/B978-0-444-64012-3.00025-3
_zAvailable from publisher's website
999 _c30312956
_d30312956